Codexis Inc (NASDAQ: CDXS) on Tuesday, plunged -10.16% from the previous trading day, before settling in for the closing price of $2.51. Within the past 52 weeks, CDXS’s price has moved between $1.90 and $6.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4.02%. The company achieved an average annual earnings per share of 19.26%. With a float of $80.50 million, this company’s outstanding shares have now reached $81.85 million.
Let’s determine the extent of company efficiency that accounts for 188 employees. In terms of profitability, gross margin is 68.36%, operating margin of -98.33%, and the pretax margin is -109.94%.
Codexis Inc (CDXS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Codexis Inc is 2.83%, while institutional ownership is 79.71%. The most recent insider transaction that took place on Apr 30 ’25, was worth 57,660. In this transaction 10% Owner of this company bought 25,000 shares at a rate of $2.31, taking the stock ownership to the 9,655,000 shares. Before that another transaction happened on May 01 ’25, when Company’s 10% Owner bought 20,000 for $2.32, making the entire transaction worth $46,436. This insider now owns 9,675,000 shares in total.
Codexis Inc (CDXS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 19.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.38% during the next five years compared to -33.31% drop over the previous five years of trading.
Codexis Inc (NASDAQ: CDXS) Trading Performance Indicators
Codexis Inc (CDXS) is currently performing well based on its current performance indicators. A quick ratio of 4.10 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.90, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of Codexis Inc (CDXS)
Looking closely at Codexis Inc (NASDAQ: CDXS), its last 5-days average volume was 0.59 million, which is a drop from its year-to-date volume of 0.83 million. As of the previous 9 days, the stock’s Stochastic %D was 58.73%. Additionally, its Average True Range was 0.19.
During the past 100 days, Codexis Inc’s (CDXS) raw stochastic average was set at 8.61%, which indicates a significant decrease from 38.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.97% in the past 14 days, which was lower than the 86.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.60, while its 200-day Moving Average is $3.55. However, in the short run, Codexis Inc’s stock first resistance to watch stands at $2.45. Second resistance stands at $2.63. The third major resistance level sits at $2.74. If the price goes on to break the first support level at $2.16, it is likely to go to the next support level at $2.05. Now, if the price goes above the second support level, the third support stands at $1.87.
Codexis Inc (NASDAQ: CDXS) Key Stats
Market capitalization of the company is 186.82 million based on 82,845K outstanding shares. Right now, sales total 59,350 K and income totals -65,280 K. The company made 21,460 K in profit during its latest quarter, and -10,380 K in sales during its previous quarter.
